Citation: Pj. Hesketh, Potential role of the NK1 receptor antagonists in chemotherapy-induced nausea and vomiting, SUPP CARE C, 9(5), 2001, pp. 350-354
Authors:
Hesketh, PJ
Crews, JR
Cohen, R
Blackburn, LM
Friedman, CJ
Citation: Pj. Hesketh et al., Antiemetic efficacy of single-dose oral granisetron (1 mg vs 2 mg) with moderately emetogenic chemotherapy, CANCER J, 6(3), 2000, pp. 157-161
Citation: M. Capanu et al., Design, fabrication, and testing of a bistable electromagnetically actuated microvalve, J MICROEL S, 9(2), 2000, pp. 181-189
Authors:
Hesketh, PJ
Roman, A
Hesketh, AM
Perez, EA
Edelman, M
Gandara, DR
Citation: Pj. Hesketh et al., Control of high-dose-cisplatin-induced emesis with an all-oral three-drug antiemetic regimen, SUPP CARE C, 8(1), 2000, pp. 46-48
Citation: Pj. Hesketh, Comparative review of 5-HT3 receptor antagonists in the treatment of acutechemotherapy-induced nausea and vomiting, CANCER INV, 18(2), 2000, pp. 163-173
Citation: Jpa. Ioannidis et al., Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting: A meta-analysis of randomized evidence, J CL ONCOL, 18(19), 2000, pp. 3409-3422
Authors:
Hesketh, PJ
Crowley, JJ
Burris, HA
Williamson, SK
Balcerzak, SP
Peereboom, D
Goodwin, JW
Gross, HM
Moore, DF
Livingston, RB
Gandara, DR
Citation: Pj. Hesketh et al., Evaluation of docetaxel in previously untreated extensive-stage small celllung cancer: A Southwest Oncology Group phase II trial, CA J SCI AM, 5(4), 1999, pp. 237-241
Authors:
Safran, H
Akerman, P
Cioffi, W
Gaissert, H
Joseph, P
King, T
Hesketh, PJ
Wanebo, H
Citation: H. Safran et al., Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction, SEM RAD ONC, 9(2), 1999, pp. 53-57
Authors:
Gralla, RJ
Osoba, D
Kris, MG
Kirkbride, P
Hesketh, PJ
Chinnery, LW
Clark-Snow, R
Gill, DP
Groshen, S
Grunberg, S
Koeller, JM
Morrow, GR
Perez, EA
Silber, JH
Pfister, DG
Citation: Rj. Gralla et al., Recommendations for the use of antiemetics: Evidence-based, clinical practice guidelines, J CL ONCOL, 17(9), 1999, pp. 2971-2994
Authors:
Hesketh, PJ
Gralla, RJ
Webb, RT
Ueno, W
DelPrete, S
Bachinsky, ME
Dirlam, NL
Stack, CB
Silberman, SL
Citation: Pj. Hesketh et al., Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis, J CL ONCOL, 17(1), 1999, pp. 338-343
Authors:
Metlushko, V
Welp, U
Crabtree, GW
Osgood, R
Bader, SD
DeLong, LE
Zhang, Z
Brueck, SRJ
Ilic, B
Chung, K
Hesketh, PJ
Citation: V. Metlushko et al., Interstitial flux phases in a superconducting niobium film with a square lattice of artificial pinning centers, PHYS REV B, 60(18), 1999, pp. R12585-R12588
Authors:
Metlushko, V
Welp, U
Crabtree, GW
Zhang, Z
Brueck, SRJ
Watkins, B
DeLong, LE
Ilic, B
Chung, K
Hesketh, PJ
Citation: V. Metlushko et al., Nonlinear flux-line dynamics in vanadium films with square lattices of submicron holes, PHYS REV B, 59(1), 1999, pp. 603-607
Authors:
Navari, RM
Reinhardt, RR
Gralla, RJ
Kris, MG
Hesketh, PJ
Khojasteh, A
Kindler, H
Grote, TH
Pendergrass, K
Grunberg, SM
Carides, AD
Gertz, BJ
Citation: Rm. Navari et al., Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptorantagonist, N ENG J MED, 340(3), 1999, pp. 190-195